KR20150113513A - Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening - Google Patents
Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening Download PDFInfo
- Publication number
- KR20150113513A KR20150113513A KR1020140037547A KR20140037547A KR20150113513A KR 20150113513 A KR20150113513 A KR 20150113513A KR 1020140037547 A KR1020140037547 A KR 1020140037547A KR 20140037547 A KR20140037547 A KR 20140037547A KR 20150113513 A KR20150113513 A KR 20150113513A
- Authority
- KR
- South Korea
- Prior art keywords
- whitening
- weight
- cosmetic composition
- extract
- skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 80
- 230000002087 whitening effect Effects 0.000 title claims abstract description 75
- 239000002537 cosmetic Substances 0.000 title claims abstract description 52
- 239000000284 extract Substances 0.000 title claims description 31
- 230000000694 effects Effects 0.000 title abstract description 27
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 15
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 15
- 235000021014 blueberries Nutrition 0.000 claims abstract description 15
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000006071 cream Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 7
- 244000171263 Ribes grossularia Species 0.000 claims description 4
- 235000002357 Ribes grossularia Nutrition 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims description 3
- 241000723298 Dicentrarchus labrax Species 0.000 claims description 2
- 229910052956 cinnabar Inorganic materials 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000002199 base oil Substances 0.000 claims 1
- 239000003240 coconut oil Substances 0.000 claims 1
- 235000019864 coconut oil Nutrition 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003549 soybean oil Substances 0.000 claims 1
- 235000012424 soybean oil Nutrition 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 32
- 230000003078 antioxidant effect Effects 0.000 abstract description 18
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 9
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 244000146462 Centella asiatica Species 0.000 abstract description 2
- 235000004032 Centella asiatica Nutrition 0.000 abstract description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 241000414067 Inonotus obliquus Species 0.000 abstract 1
- 241000001727 Tropicoporus linteus Species 0.000 abstract 1
- 239000010685 fatty oil Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 13
- 102000003425 Tyrosinase Human genes 0.000 description 12
- 108060008724 Tyrosinase Proteins 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 11
- 230000008099 melanin synthesis Effects 0.000 description 9
- 239000002131 composite material Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- 238000002845 discoloration Methods 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 5
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 5
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229920006008 lipopolysaccharide Polymers 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 238000011076 safety test Methods 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GFBCWCDNXDKFRH-UHFFFAOYSA-N 4-(oxan-2-yloxy)phenol Chemical compound C1=CC(O)=CC=C1OC1OCCCC1 GFBCWCDNXDKFRH-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 241000355169 Acanthopus Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000220285 Crassula Species 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 230000010718 Oxidation Activity Effects 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- ZZTYPLSBNNGEIS-OPAXANQDSA-N Pomolic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@](O)(C)[C@H]5C4=CC[C@@H]3[C@]21C ZZTYPLSBNNGEIS-OPAXANQDSA-N 0.000 description 1
- JYEJQUHSBMDABO-SYKQLJDKSA-N Pomolic acid Natural products C[C@@H]1CC[C@@]2(CC[C@H]3[C@@H]4CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2[C@]1(C)O)C(=O)O JYEJQUHSBMDABO-SYKQLJDKSA-N 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 108010083387 Saralasin Proteins 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000024181 negative regulation of developmental pigmentation Effects 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- PFGWGEPQIUAZME-NXSMLHPHSA-N saralasin Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)C1=CC=C(O)C=C1 PFGWGEPQIUAZME-NXSMLHPHSA-N 0.000 description 1
- 229960004785 saralasin Drugs 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- -1 superoxide anion radicals Chemical class 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 208000014001 urinary system disease Diseases 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 천연 미백복합물을 함유하는 미백화장료 조성물에 관한 것이다.The present invention relates to a whitening cosmetic composition containing a natural whitening composite.
최근 들어 피부미용에 대한 관심이 높아지고 있는데, 피부에서 기미, 주근깨와 같은 색소 침착은 자외선과 같은 인자에 기인된 것으로 멜라닌 생성 혹은 멜라닌 세포의 증식에 의하여 일어난다. 피부에서의 색소 침착은 tyrosinase 활성을 감소 시켜서 억제할 수 있는데, melanocyte의 기능을 감소키시거나 혹은 melanin 생성을 감소시켜서 색소 침착을 억제할 수 있다. 또한 자동 산화 반응을 억제함으로써 melanin 생성을 감소시킬 수 있으며 자외선 조사로 생기는 홍반과 같은 염증 반응을 억제함으로서 색소 침착을 억제할 수 있다고 알려져 있다(Case, D. B., Wallace, J. M., Keim, H. J., Weber, M. A., Drayer, J. I. M.,White, R. P., Sealey, J. E. and Laragh, J. H. : Estimating renin participation in hypertension : Superiority of converting enzyme inhibitor over saralasin, Am . J. Med., 61, p.790(1976)).In recent years, interest in skin beauty has been increasing, and skin pigmentation such as spots and freckles in the skin is caused by factors such as ultraviolet rays, which are caused by melanin production or melanocyte proliferation. Pigmentation in the skin can be inhibited by reducing tyrosinase activity, which can reduce melanocyte function or reduce melanin production and inhibit pigmentation. In addition, it is known that melanin production can be reduced by inhibiting autoxidation reaction, and it is known that inhibition of pigmentation can be suppressed by suppressing inflammatory reaction such as erythema caused by ultraviolet irradiation (Case, DB, Wallace, JM, Keim, MA, Drayer, JM, White, RP, Sealey, JE and Laragh, JH: Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin, Am . J. Med ., 61, p.
현제 세계적으로 화장품에 널리 사용되고 있는 미백제는 hydroquinone이나 arbutin등이 있는데, tyrosinase 저해제이다. 최근 P&G(Procter & Gamble)에서 arbutin 유도체인 deoxy arbutin에 대한 보고를 한 바 있으며, 국내에서도 arbutin 등의 유도체 개발을 시도하고 있다. Currently, whitening agents that are widely used in cosmetics worldwide include hydroquinone and arbutin, which are tyrosinase inhibitors. Recently, P & G (Procter & Gamble) reported deoxy arbutin, an arbutin derivative, and tried to develop derivatives such as arbutin in Korea.
대한민국 특허 제10-0535875호에서는 식물 혼합 추출물을 이용하여 미백 화장료 조성물에 관한 것으로서, 멜라닌 생합성을 억제하기 위해 tyrosinase 활성 저해와 B16에 의한 멜라닌 생성을 억제하는 것을 특징으로 한다. 대한민국 특허 제10-1086669호에서는 청미래덩굴 추출물을 함유하는 미백용 화장료 조성물에 관한 것인데, 청미래덩굴 뿌리의 디오신, 사포닌, 알칼로이드 성분이 피부에서 tyrosinase 활성 및 DOPA의 산화 활성을 저해함으로서 멜라닌 생성을 억제하는 것에 관한 것이다. 대한민국 특허 제10-0471685호에서는 락테이트 및 상지추출물을 유효성분으로 하는 미백 화장료 조성물에 관한 것으로서, 피부 자극 없이 멜라닌 생성을 억제에 관한 것이다.Korean Patent No. 10-0535875 is directed to a whitening cosmetic composition using a plant mixture extract and is characterized by inhibiting tyrosinase activity and melanin production by B16 in order to inhibit melanin biosynthesis. Korean Patent No. 10-1086669 discloses a cosmetic composition for skin whitening comprising a Crassulaceae extract, wherein the diphosphine, saponin, and alkaloid components of the Crassula japonica root inhibit melanin production by inhibiting tyrosinase activity and DOPA oxidation activity in the skin Lt; / RTI > Korean Patent No. 10-0471685 relates to a whitening cosmetic composition comprising lactate and topical extract as an active ingredient, and relates to inhibiting melanin production without skin irritation.
상기 발명은 단순히 tyronisase 억제 및 멜라닌 생성 억제에 관한 효과를 부여하는 것으로서 거의 효과가 미비하고, 근본적인 개선이 어려운 단점을 가지고 있다. 따라서 멜라닌 생성 억제와 동시에 산화로 인한 피부세포를 보호하고, 세포의 정상적인 성장 및 턴오버 효과를 가질 수 있는 세포재생효과등 다양한 메커니즘을 개선하여 미백효과를 획기적으로 부여할 수 있는 화장료 조성물이 필요 하다.
The above-mentioned invention is merely to provide effects on inhibition of tyrosinase and inhibition of melanin production, and it has almost no effect and has a disadvantage that it is difficult to fundamentally improve. Therefore, there is a need for a cosmetic composition which can remarkably exert a whitening effect by improving various mechanisms such as melanin production inhibition, protection of skin cells due to oxidation, cell regeneration effect capable of normal growth and turnover of cells .
이에, 본 발명자는 피부 자극이 없으며, 미백효과가 우수한 화장료를 개발하기 위해 연구한 결과, 지유, 병풀, 블루베리, 가시오가피, 상황버섯, 차가버섯의 천연복합 추출물을 포함하는 화장료 조성물이 미백효과, 항산화 효과, 항염증 효과, 세포재생 효과가 뛰어남을 알게 되어 본 발명을 완성하였다. The inventors of the present invention have conducted studies to develop a cosmetic composition having no skin irritation and excellent whitening effect, and as a result, it has been found that a cosmetic composition comprising a natural combination extract of Jiu-yu, Cilotheri, Blueberry, Acanthopanax senticosus, Antioxidative effect, antiinflammatory effect and cell regeneration effect are excellent. Thus, the present invention has been completed.
이에 본 발명자들은 미백효과를 부여하기 위해 화장료 조성물을 연구하던 중, 피부 자극이 없으며, 미백효과, 항산화 효과, 항염증 효과, 세포재생 효과가 우수한 미백 조성물을 발견하고 본 발명을 완성하게 되었다. Accordingly, the inventors of the present invention discovered a whitening composition having no whitening effect, whitening effect, antioxidative effect, antiinflammatory effect, and cell regeneration effect while studying a cosmetic composition for imparting a whitening effect, and completed the present invention.
따라서, 본 발명이 해결하고자 하는 기술적 과제는 천연 미백복합물을 함유하는 미백화장료 조성물을 제공하는 것이다.Accordingly, it is a technical object of the present invention to provide a whitening cosmetic composition containing a natural whitening composite.
상기 목적을 달성하기 위하여, 본 발명에서는 0.01 ~ 20중량%의 천연복합 추출물 함유하여 미백 효과를 획기적으로 부여할 수 있는 미백 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a whitening cosmetic composition containing 0.01 to 20% by weight of a natural compound extract and capable of remarkably imparting a whitening effect.
상기 천연 미백복합물을 함유하는 미백화장료 조성물은 스킨, 로션, 에센스, 세럼, 크림, 아이크림, 마스크팩, 폼클렌저, 메이크업, 투웨이케익, 비비크림, 선크림, 바디케어제품, 헤어케어제품등으로 구성된 군으로부터 선택된 어느 하나의 제형인 것을 특징으로 한다.The whitening cosmetic composition containing the natural whitening composition may be a skin, a lotion, an essence, a serum, a cream, an eye cream, a mask pack, a foam cleanser, a makeup, a two-way cake, a babe cream, And a pharmaceutically acceptable carrier.
본 발명에 의한 천연 미백복합물을 함유하는 미백화장료 조성물은 피부 자극이 없으며, 미백효과, 항산화 효과, 세포재생 효과 등이 뛰어나며, 트러블 및 자극이 없어 사용자의 만족도가 높다.The whitening cosmetic composition containing the natural whitening composite according to the present invention is free of skin irritation, has excellent whitening effect, antioxidative effect, cell regeneration effect, and satisfies the user with no trouble and irritation.
도 1은 실시예 1, 2에서 제조한 천연 미백복합물의 항산화 활성인DPPH 저해활성 그래프.
도 2는 실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 항산화 활성인 SOD 유사활성 그래프.
도 3은 실시예 1에서 제조한 피부 미백용 화장료 조성물의 항염증 결과 그래프.
도 4는 실시예 1에서 제조한 피부 미백용 화장료 조성물의 항염증 결과 그래프.
도 5는 실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 세포독성 결과 그래프.
도 6은 실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 미백효과인 Tyrosinase 저해활성 결과 그래프.1 is a DPPH inhibitory activity antioxidative activity of the natural whitening composite prepared in Examples 1 and 2;
Fig. 2 is a SOD-like activity graph showing the antioxidative activity of the skin whitening cosmetic composition prepared in Examples 1 and 2. Fig.
Fig. 3 is a graph showing anti-inflammatory results of the cosmetic composition for skin whitening produced in Example 1. Fig.
4 is a graph showing anti-inflammation results of the cosmetic composition for skin whitening produced in Example 1. Fig.
5 is a graph of cytotoxicity results of the skin whitening cosmetic compositions prepared in Examples 1 and 2;
FIG. 6 is a graph showing the results of tyrosinase inhibition activity as a whitening effect of the cosmetic composition for skin whitening prepared in Examples 1 and 2. FIG.
이하, 본 발명을 상세히 설명하면 다음과 같다.
Hereinafter, the present invention will be described in detail.
본 발명의 천연 미백복합물을 함유하는 미백화장료 조성물은 지유, 병풀, 블루베리, 가시오가피, 상황버섯 및 차가버섯의 추출물을 포함한다.
The whitening cosmetic composition containing the natural whitening complex of the present invention includes an extract of the oil palm, the cinnabar, the blueberry, the sea bass, the mushroom and the chaga mushroom.
상기 지유는 오이풀이라고도 불리며, 중국, 일본, 우리나라 전 지역에서 널리 분포하고 있는 장미과에 속하는 다년생 식물로 뿌리를 생약에서 지유라고 한다. 화상, 염증 및 내부 출혈의 치료에 대해 중국의 전통 의학에 사용되어진 기록이 있다. 지유의 약리성분으로는 ziguglycoside I, II와 pomolic acide등이 함유되어 있어 우수한 항산화 및 미백활성을 가지고 있다. 본 발명에서 지유는 혼합되는 조성물의 전체 건조 중량을 기준으로 10~30중량%로 혼합되는 것이 바람직하며, 10중량% 미만 혼합되면 효과가 거의 나타나지 않는 문제가 있으며, 30중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
It is a perennial plant belonging to the rose family, which is widely distributed in China, Japan, and all parts of Korea. There is a record used in traditional Chinese medicine for the treatment of burns, inflammation and internal bleeding. The phytonutrients of zygus contains the ziguglycoside I, II and pomolic acid, which have excellent antioxidative and whitening activity. In the present invention, the coarse oil is preferably mixed in an amount of 10 to 30% by weight based on the total dry weight of the composition to be mixed. When the coarse oil is mixed in an amount of less than 10% by weight, There is a problem of physical properties such as discoloration and lowering of viscosity.
상기 병풀(Centella asiatica)은 쌍떡잎식물 이판화군 산형화목 미나리과의 여러해살이풀로서, 다소 습기가 있는 곳에서 자라며, 옆으로 뻗어가면서 마디에서 뿌리가 내리고 비늘 같은 잎이 있다. 세포 재생 효과와 항염증효과가 우수하다. 본 발명에서 병풀은 혼합되는 조성물의 전체 건조 중량을 기준으로 10~30중량%로 혼합되는 것이 바람직하며, 효과가 거의 나타나지 않는 문제가 있으며, 30중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
Centella asiatica is a perennial herbaceous herbaceous plant of the dicotyledonous herbaceous plant of the dicotyledonous plant family. It grows in a somewhat moist place. Its root extends from side to side and has scaly leaves. Cell regeneration effect and anti-inflammatory effect are excellent. In the present invention, it is preferable to mix 10 to 30% by weight based on the total dry weight of the composition to be mixed, and there is a problem that little effect is exhibited. When the composition is mixed in an amount of more than 30% by weight, There is a property problem.
상기 블루베리는 푸른색으로 상징되는 안토시안 색소, 새콤달콤한 당분, 점성이 있는 펙틴, 은은한 향기등이 있다. 열매와 잎의 엑기스는 괴혈병, 당뇨병, 비뇨기 질환 등의 치료에 사용해왔고, 최근 연구를 통해 안토시아닌에 의해 강력한 항산화효과로 가지고 있다고 알려져 있다. 본 발명에서 블루베리는 혼합되는 조성물의 전체 건조 중량을 기준으로 10~20중량%로 혼합되는 것이 바람직하며, 10중량% 미만 혼합되면 효과가 거의 나타나지 않는 문제가 있으며, 20중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
The blueberry has an anthocyanin color, blue sugar, sour sweet sugar, viscous pectin, and a fragrant scent. Fruit and leaf extract have been used for the treatment of scurvy, diabetes, and urinary disease, and it is known that they have a strong antioxidant effect by anthocyanins in recent studies. In the present invention, the blueberries are preferably mixed in an amount of 10 to 20% by weight based on the total dry weight of the composition to be mixed. When less than 10% by weight is mixed, the effect is hardly exhibited. There is a problem of physical properties such as discoloration and viscosity decrease.
상기 가시오가피는 가시오갈피나무라고도 불리며, 전국 각지의 깊은 산골짜기에서 자란다. 항산화, 항염증, 아토피 피부 개선에 효과가 우수하다. 본 발명에서 가시오가피는 혼합되는 조성물의 전체 건조 중량을 기준으로 10~20중량%로 혼합되는 것이 바람직하며, 10중량% 미만 혼합되면 효과가 거의 나타나지 않는 문제가 있으며, 20중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
It is also known as Acanthopus spp., And it grows in deep valleys throughout the country. Antioxidant, anti-inflammatory, and atopic skin. In the present invention, the viscose is preferably mixed in an amount of 10 to 20% by weight based on the total dry weight of the composition to be mixed. When the content is less than 10% by weight, the effect is hardly exhibited. There is a problem of physical properties such as discoloration and lowering of viscosity.
상기 상황버섯은 목질진흙버섯이라고도 하며, 동의보감에서는 상목이라는 이름으로 탕액편에 기록되어 있다. 항암효과가 우수하다고 알려져 있고, 항산화 및 미백효과가 탁월하다. 본 발명에서 상황버섯은 혼합되는 조성물의 전체 건조 중량을 기준으로 5~10중량%로 혼합되는 것이 바람직하며, 5중량% 미만 혼합되면 효과가 거의 나타나지 않는 문제가 있으며, 10중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
The above-mentioned mushroom is also referred to as woody mud mushroom, and it is recorded in the name of mushroom in the name of " It is known that the anticancer effect is excellent, and the antioxidative and whitening effect is excellent. In the present invention, the mushroom is preferably mixed in an amount of 5 to 10% by weight based on the total dry weight of the composition to be mixed. When the mushroom is mixed in an amount of less than 5% by weight, There is a problem of physical properties such as discoloration and viscosity decrease.
상기 차가버섯은 시베리아와 북아메리카, 북유럽 등 북위 45도 이상 지방의 자작나무에 기생하는 버섯으로 암 등 성인병 치료에 효능이 뛰어나다. 화장품 약리활성으로는 보습 및 진정효과가 탁월하고, 미백효과가 우수한 것이 특징이다. 본 발명에서 차가버섯은 혼합되는 조성물의 전체 건조 중량을 기준으로 5~10중량%로 혼합되는 것이 바람직하며, 5중량% 미만 혼합되면 효과가 거의 나타나지 않는 문제가 있으며, 10중량% 초과 혼합되면 제품의 변색 및 점도 저하등의 물성 문제가 있다.
The mushroom is a mushroom parasitized on birch of Siberia, North America, northern Europe and more than 45 degrees north latitude, and is excellent for the treatment of adult diseases such as cancer. The pharmacological activity of cosmetics is characterized by excellent moisturizing and soothing effects and excellent whitening effect. In the present invention, chaga mushrooms are preferably mixed in an amount of 5 to 10% by weight based on the total dry weight of the composition to be mixed. When mixed in less than 5% by weight, the effect is hardly exhibited. There is a problem of physical properties such as discoloration and viscosity decrease.
본 발명에 따른 천연 미백복합물은, The natural whitening complex according to the present invention,
지유 10~30중량%, 병풀 10~30중량%, 블루베리 10~20중량%, 가시오가피 10~20중량%, 상황버섯 5~10중량%, 차가버섯 5~10중량%를 혼합한 추출물을 포함한다.
10 to 30% by weight of ground oil, 10 to 30% by weight of blueberry, 10 to 20% by weight of blueberry, 10 to 20% by weight of gooseberry, 5 to 10% by weight of mushroom and 5 to 10% do.
한편, 본 발명에 따른 천연 미백 복합 조성물의 제조방법은 다음과 같다.The method for preparing the natural whitening complex composition according to the present invention is as follows.
본 발명의 천연 미백복합 조성물의 제조방법은,The method for producing a natural whitening complex composition of the present invention comprises:
지유 10~30중량%, 병풀 10~30중량%, 블루베리 10~20중량%, 가시오가피 10~20중량%, 상황버섯 5~10중량%, 차가버섯 5~10중량%를 혼합하여 혼합물을 만드는 단계(단계 1);10 to 30% by weight of ground oil, 10 to 30% by weight of blueberry, 10 to 20% by weight of blueberry, 10 to 20% by weight of gooseberry, 5 to 10% by weight of mushroom and 5 to 10% Step (step 1);
상기 혼합물을 물 또는 에탄올 수용액으로 추출하여 추출물을 만드는 단계(단계 2); 및Extracting the mixture with water or an aqueous ethanol solution to prepare an extract (step 2); And
상기 추출물을 여과 및 농축하여 천연 미백복합 조성물을 제조하는 단계(단계 3);Filtering and concentrating the extract to prepare a natural whitening complex composition (step 3);
를 포함한다.
.
상기 단계 1에서, 상기 천연원료들은 물로 세척하고 건조한 후 세절하여 혼합하는 것이 바람직하다.
In step 1, the natural raw materials are preferably washed with water, dried, and then finely mixed.
상기 단계 2에서, 상기 혼합물에 8~10배 부피의 물을 넣고 80~85에서 2~4시간 동안 열수 추출하거나, 상기 혼합물에 8~10배 부피의 에탄올 수용액을 넣고 20~25에서 20~24시간 동안 용매 추출하는 것이 바람직하다. 상기 에탄올 수용액은 에탄올과 물이 7:3의 부피비로 이루어지는 것이 바람직하다. In step 2, 8 to 10 times volume of water is added to the mixture, followed by hot extraction at 80 to 85 for 2 to 4 hours, or 8 to 10 times volume of an aqueous ethanol solution is added to the mixture, Solvent extraction is preferred. The ethanol aqueous solution preferably has a volume ratio of ethanol and water of 7: 3.
상기 열수 추출 및 용매 추출은 3회 반복적으로 추출하는 것이 바람직하다.
The hot water extraction and the solvent extraction are preferably repeated three times.
상기 단계 3에서, 상기 여과는 상기 추출물을 여과지에 통과시켜 잔재물을 제거한 후 로터리감압농축기를 이용하여 40~45에서 6~8시간 동안 농축하는 것이 바람직하다.
In step 3, the filtrate is preferably passed through a filter paper to remove the residue, and then concentrated using a rotary vacuum concentrator at 40-45 for 6-8 hours.
한편, 본 발명에 따른 천연 미백복합물을 함유하는 미백화장료 조성물은 천연 미백복합 조성물의 총 중량에 대하여 0.01~20 중량%로 함유시켜 제조할 수 있으며, 바람직하게는 0.1~10중량% 함유시켜 제조할 수 있다. 상기 천연 미백복합 조성물이 0.01 중량% 미만 함유되면 미백효과가 미미한 문제가 있으며, 20중량% 초과 사용하면 최종제품의 물성이 저하되고 변색이 발생하는 문제가 있다. On the other hand, the whitening cosmetic composition containing the natural whitening composite according to the present invention can be prepared by containing 0.01 to 20% by weight, preferably 0.1 to 10% by weight, based on the total weight of the natural whitening complex composition . When the natural whitening composite composition is contained in an amount less than 0.01% by weight, there is a problem that the whitening effect is insignificant. When the natural whitening complex composition is used in an amount exceeding 20% by weight, the physical properties of the final product are deteriorated and discoloration occurs.
상기 천연 미백복합물을 함유하는 미백화장료 조성물은 스킨, 로션, 에센스, 세럼, 크림, 아이크림, 마스크팩, 폼클렌저, 메이크업, 투웨이케익, 비비크림, 선크림, 바디케어제품, 헤어케어제품등으로 구성된 군으로부터 선택된 어느 하나의 제형인 것을 특징으로 한다.
The whitening cosmetic composition containing the natural whitening composition may be a skin, a lotion, an essence, a serum, a cream, an eye cream, a mask pack, a foam cleanser, a makeup, a two-way cake, a babe cream, And a pharmaceutically acceptable carrier.
이하, 실시 예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시 예는 오로지 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들 실시 예에 의해 제한되는 것은 아니다.
Hereinafter, the constitution and effects of the present invention will be described in more detail through examples. These embodiments are only for illustrating the present invention, and the scope of the present invention is not limited by these embodiments.
실시예 1Example 1
지유 250g, 병풀 250g, 블루베리 150g, 가시오가피 150g, 상황버섯 100g 및 차가버섯 100g을 물로 세척한 후 수분함유 10 % 이하로 건조하고 크기 1 ~ 3 로 세절하고 혼합하여 혼합물 만들었다. 250g of jelly, 250g of blueberry, 150g of blueberry, 150g of Ganoderma Lucidum, 100g of Shiitake mushroom and 100g of Shiitake mushroom were washed with water, dried to less than 10% moisture content, and finely divided into 1 to 3 pieces to prepare a mixture.
상기 혼합물에 10배 부피의 물을 넣고 85에서 3시간 동안 열수 추출하였으며, 3회 반복 추출하여 추출물을 만들었다.10 times volume of water was added to the mixture, and the mixture was subjected to hot extraction for 3 hours at 85 ° C, and extracted three times to obtain an extract.
상기 추출물을 여과지(Adventec No.2)에 통과시켜 잔재물을 제거한 후 로터리감압농축기(HS-10P, Hanshin)를 이용하여 45에서 8시간 동안 농축하여 천연 미백복합 조성물을 제조하였다.
The extract was passed through a filter paper (Adventec No. 2) to remove the residue, and then concentrated using a rotary vacuum concentrator (HS-10P, Hanshin) at 45 for 8 hours to prepare a natural whitening composite composition.
실시예 2Example 2
실시예 1에서 열수 추출하는 대신, 상기 혼합물에 10배 부피의 에탄올 수용액(에탄올:물=7:3 부피비)을 넣고 25에서 24시간 동안 추출하였으며, 3회 반복 추출하여 추출물을 만든 것을 제외하고 나머지는 동일하게 하여, 피부 미백용 화장료 조성물을 제조하였다.
(Ethanol: water = 7: 3 by volume) was added to the above mixture instead of hot water extraction in Example 1, and the mixture was extracted for 25 to 24 hours. , A cosmetic composition for skin whitening was prepared.
[실험예 1][Experimental Example 1]
실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 항산화 효과를 알아보기 위하여 전자공여능을 측정하였다. 대조군은 합성 항산화제인 BHA(butylated hydroxyanisole)를 사용하였다.The electron donating ability was measured to examine the antioxidative effect of the skin whitening cosmetic composition prepared in Examples 1 and 2. BHA (butylated hydroxyanisole), a synthetic antioxidant, was used as a control.
전자공여능(EDA, electron donating abilities)은 Blois 등의 방법(Blois, M. S. : Antioxidant determination by the use of a stable free radical. Nature, 181, 1190-1200, 1958)을 변형하여 다음과 같이 측정하였다. 일정 농도의 시료용액 100에 0.2mM의 DPPH(1,1-diphenyl-2-picryl-hydrazyl) 50 넣고 교반한 후 30분간 실온에서 반응한 후, 517에서 흡광도를 측정하여 도 1에 나타내었다.The electron donating ability (EDA) was measured by the modified Blois method (Blois, M. S.: Antioxidant determination by the use of a stable free radical. Nature, 181, 1190-1200, 1958) as follows. 0.2 mM DPPH (1,1-diphenyl-2-picryl-hydrazyl) 50 was added to a
도 1을 보면, 실시예 1, 2의 피부 미백용 화장료 조성물이 대조군인 합성 항산화제(BHA)와 유사한 항산화 활성을 나타낸 것을 알 수 있으며, 실시예 2의 에탄올(Ethanol) 수용액 추출물이 실시예 1의 열수(Water) 추출물 보다 효과적인 항산화 활성인 전자공여능을 나타낸 것을 알 수 있다.
1 shows that the skin whitening cosmetic compositions of Examples 1 and 2 exhibited antioxidative activities similar to those of synthetic antioxidant (BHA) as a control group, and that the ethanol aqueous solution extract of Example 2 was similar to Example 1 Which is an effective antioxidant activity, than the water extract of the present invention.
[실험예 2][Experimental Example 2]
실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 항산화 효과를 알아보기 위하여 SOD 유사활성(Superoxide Dismutade-like Activity)을 측정하였다. 대조군은 BHA를 사용하였다.To examine the antioxidative effect of the skin whitening cosmetic compositions prepared in Examples 1 and 2, SOD-like activity (Superoxide Dismutade-like Activity) was measured. The control group was BHA.
SOD 유사활성은 Marklund 등의 방법(Marklund, S. and Marklund, G. : Involvement of superoxide anion radical in the oxidation of pyrogallol and a convenient assay for superoxide desmutase. Eur. J. Biochem., 47, 468, 1974)을 변형하여 측정하였다. 일정 농도의 시료용액 20에 Tris-HCl 완충용액(50mM tris + 10mM EDTA, pH 8.5) 260와 7.2mM pyrogallol 20 가하여 25에서 10분간 반응시킨 후 5N HCl 10를 가하여 반응을 정지시키고 반응액 중 산화된 pyrogallol의 양을 420 에서 측정하여 도 2에 나타내었다.SOD-like activity was measured by the method of Marklund et al. (Marklund, S. and Marklund, G.: Involvement of superoxide anion radicals in pyroalloy and a convenient assay for superoxide desmutase, Eur. J. Biochem., 47, 468, 1974) . The reaction was stopped by adding 25% Tris-HCl buffer solution (50 mM tris + 10 mM EDTA, pH 8.5) 260 and 7.2
도 2를 보면, 500ppm 이상에서 실시예 2의 에탄올(Ethanol) 수용액 추출물의 경우 대조군인 BHA와 유사한 활성을 나타내어 강력한 SOD 유사 활성을 나타낸 것을 알 수 있다.
FIG. 2 shows that the extract of aqueous ethanol (ethanol) of Example 2 at 500 ppm or higher exhibited similar activity to BHA as the control group, indicating strong SOD-like activity.
[실험예 3][Experimental Example 3]
실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 항염증 효과를 알아보기 위하여 Nitric Oxide 저해활성을 측정하였다. 염증을 일으키는 자극원은 LPS(Lipopolysccharide)를 사용하였다.In order to examine the anti-inflammatory effects of the skin whitening cosmetic compositions prepared in Examples 1 and 2, Nitric Oxide inhibitory activity was measured. Lipopolysaccharide (LPS) was used to stimulate inflammation.
Raw 264.7 cell로부터 생성된 Nitric Oxide의 양은 Byun 등의 방법(Byun, S. H., Yang, C. H. and Kim, S. C. : Inhibitory effect of Scrophulariae Radix extract on TNF-a, IL-1, IL-6 and Nitric Oxide production in lipopolysaccharide-activated mouse macrophage Raw 264.7 cells. Kor. J. Ori. Herbology., 20, 7-16, 2005)에 준하여 다음과 같이 실험하였다. 세포 배양액 중에 존재하는 NO2 - 를 Griess 시약을 이용하여 측정하였다. 세포배양 상등액 100와 griess 시약 100를 혼합하여 반응하여 10분 동안 반응시킨 후 540 에서 흡광도를 측정하였다. NO2 - 의 양은 NaNO2의 표준곡선을 이용하여 정량하였다.The amount of nitric oxide produced from Raw 264.7 cells was determined by the method of Byun, SH, Yang, CH and Kim, SC: Inhibitory effect of scrophulariae radix extract on TNF-a, IL-1, IL-6 and Nitric Oxide production in lipopolysaccharide-activated mouse macrophage Raw 264.7 cells. Kor J. Ori. Herbology., 20, 7-16, 2005). NO 2 present in the cell culture - was measured using the Griess reagent.
실시예 1의 열수(Water) 추출물의 항염증효과를 도 3에 나타내었고, 실시예 2의 에탄올(Ethanol) 수용액 추출물의 항염증효과를 도 4에 나타내었다.The anti-inflammatory effect of the water extract of Example 1 is shown in FIG. 3, and the anti-inflammatory effect of the aqueous ethanol extract of Example 2 is shown in FIG.
도 3 및 도 4를 보면, 실시예 1의 열수 추출물과 실시예 2의 에탄올 수용액 추출물 모두 함량이 증가할수록 자극원인 LPS처리군 보다 염증이 가라앉는 것을 확인할 수 있다.
3 and 4, it can be seen that as the content of both the hot water extract of Example 1 and the ethanol aqueous solution of Example 2 increases, inflammation sinks more in the LPS-treated group than that of stimulation.
[실험예 4][Experimental Example 4]
실시예 1, 2에서 제조한 피부 미백용 화장료 조성물에 대해 세포 독성 시험을 하였다. 시료에 의한 Raw 264.7 세포에 미치는 영향은 Carmichael 등(Carmichael, J., De. Graff, W. G., Gazdar, A. F., Minna, J. D. and Mitchell, J. B. : Evaluation of a tetrazolium based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942, 1987)의 MTT assay를 통해 평가하였다. 96well plate에 50,000 cells/well 로 분주한 후, 80%의 confluency에 도달할 때 원배지를 제거하고 serum free EMEM으로 교제하였다. 12시간 배양 후, 시료를 농도별로 첨가하여 37, 5% CO2 incubator에서 배양하였다. 대조군은 시료와 동량의 증류를 첨가하여 동일한 조건으로 배양하였다. 여기에 5mg/ml 농도로 제조한 MTT용액 0.02를 첨가하여 4시간 후, 상층액을 제거하고 각 well 당 DMSO:EtOH(1:1)를 가하여 실온에서 30분간 반응시킨 뒤 ELISA reader로 550에서 흡광도를 측정하였다.Cytotoxicity tests were carried out on the skin whitening cosmetic compositions prepared in Examples 1 and 2. The effect of the sample on Raw 264.7 cells was evaluated by the method of Carmichael et al. (Carmichael, J., De Graff, WG, Gazdar, AF, Minna, JD and Mitchell, JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay. Cancer Res., 47, 936-942, 1987). The cells were seeded at 50,000 cells / well on a 96-well plate, and when the confluency reached 80%, the original medium was removed and cultured with serum-free EMEM. After 12 hours of incubation, samples were added at different concentrations and incubated in 37, 5% CO 2 incubator. The control group was cultured under the same conditions by adding the same amount of distillation as the sample. After 4 hours, the supernatant was removed, and the reaction was carried out at room temperature for 30 minutes in DMSO: EtOH (1: 1) per well. The absorbance of the MTT solution was measured at 550 using an ELISA reader Were measured.
에탄올추출물에 의한 macrophage 세포의 생존율을 MTT assay에 의해 확인한 결과를 도 5에 나타내었다. The results of confirming the survival rate of macrophage cells by ethanol extract by MTT assay are shown in Fig.
도 5을 보면, 세포 독성으로 인한 cell population의 저하에서 기인하는 것인지를 측정한 결과, 모든 농도에서 세포에 영향을 미치지 않아 세포에 의한 독성은 거의 없는 것을 확인할 수 있다.
As shown in FIG. 5, it was determined whether or not the cell population was caused by a decrease in the cell population due to cytotoxicity.
[실험예 5][Experimental Example 5]
실시예 1, 2에서 제조한 피부 미백용 화장료 조성물의 미백효과를 알아보기 위하여 Tyrosinase 억제능을 측정하였다.In order to examine the whitening effect of the skin whitening cosmetic compositions prepared in Examples 1 and 2, the tyrosinase inhibitory activity was measured.
Tyrosinase 저해활성 측정은 Yagi 등( Yagi A, Kanbara T, Morinobu N. The effect of tyrosinase inhibition for aloe. Planta Medica. 1986;3981:517-519 )의 방법에 따라 측정하였다. 반응구는 0.175M sodium phosphate buffer(pH 6.8) 0.5mL에 10mM L-DOPA를 녹인 기질 액 0.2mL 및 시료용액 0.1mL의 혼합액에 mushroom tyrosinase(110U/mL) 0.2mL를 첨가하여 37에서 2분간 반응시켜 반응 액 중에 생성된 DOPA chrome을 475nm에서 측정하였다. Tyrosinase 저해활성은 시료용액의 첨가구와 무 첨가 군의 흡광도 감소율로 나타내었다. Tyrosinase inhibitory activity was measured according to the method of Yagi et al. (Yagi A, Kanbara T, Morinobu N. The effect of tyrosinase inhibition for aloe, Planta Medica ., 1986, 3981: 517-519). To the reaction mixture, 0.2 mL of mushroom tyrosinase (110 U / mL) was added to a mixture of 0.2 mL of the substrate solution in which 10 mM L-DOPA was dissolved in 0.5 mL of sodium phosphate buffer (pH 6.8) and 0.1 mL of the sample solution, The DOPA chrome produced in the reaction solution was measured at 475 nm. Tyrosinase inhibitory activity was expressed as the absorbance reduction ratio of the sample solution and the no - sample group.
실험 결과는 도 6에 나타내었는데, 천연 복합 추출물의 함량이 증가할수록 Tyrosinase 저해 활성이 증가함을 확인할 수 있어 피부 미백에 효과가 있는 것을 확인하였다.
The results of the experiment are shown in FIG. 6. As Tyrosinase inhibitory activity is increased as the content of the natural complex extract is increased, it is confirmed that it is effective for skin whitening.
실시예 3Example 3
에탄올 추출물을 함유하는 미백 화장용 에센스 조성물을 표 1과 같이 제조하였다.
Ethanol extract was prepared as shown in Table 1.
[비교예 1][Comparative Example 1]
에탄올 추출물을 함유하지 않는 일반 에센스 조성물을 표 1과 같이 제조하였다.
A general essence composition containing no ethanol extract was prepared as shown in Table 1.
[실험예 6][Experimental Example 6]
실시예 3에서 제조된 미백 개선용 천연복합 추출을 함유한 화장료 조성물의 총호기성균 실험을 진행하였다. The total aerobic bacteria experiment of the cosmetic composition containing the natural complex extract for whitening improvement prepared in Example 3 was carried out.
총 호기성 생균수 시험법은 화장품 중 총 호기성 생균(세균, 진균)수를 측정하는 시험법이다. 총 호기성 생균수는 검출된 세균수와 진균수의 합으로 하고, 총 호기성 세균수 시험은 변형레틴액체배지 (Modified letheen broth) 또는 대두카제인소화안천배지를 사용하고 진균수 시험은 항생물질 첨가 포테이토 덱스트로즈 한천배지 또는 항생물질 첨가 사브로포도당한천배지를 사용하였다. 실험 결과 도 7에 나타내었는데, 실시예 2에서 제조된 미백 개선용 천연복합 추출을 함유한 화장료 조성물에서 세균 및 진균이 전혀 나타나지 않았다.
Total aerobic viable count is a test method to measure the total aerobic viable count (bacteria, fungi) in cosmetics. The total aerobic viable count is the sum of the detected number of bacteria and the total number of fungi. The total aerobic count is used for modified letheen broth or soybean casein digestion culture medium. The fungus count test is performed using potato dex Trough agar medium or antibiotic added sucrose agar medium was used. The results of the experiment are shown in Fig. 7. In the cosmetic composition containing the natural complex extract for whitening improvement prepared in Example 2, no bacteria or fungi were found.
[실험예 7][Experimental Example 7]
실시예 3에서 제조된 미백 개선용 천연복합 추출을 함유한 화장료 조성물의 피부안전성 실험을 실시하였다. The skin safety test of the cosmetic composition containing the natural complex extract for whitening improvement prepared in Example 3 was carried out.
미백 개선용 천연복합 추출을 함유한 화장료 조성물의 피부 안전성 실험인 첩포시험은 Waggoner 등 ( Waggoner WC, etc. Clinical safety and efficacy testing of cosmetic. Cosmetic science and Technology series. New York , Marcel Dekker . 1990:105 )을 응용하여 실시예 2에서 제조된 미백 개선용 천연복합 추출을 함유한 화장료 조성물을 판 안쪽 부위의 피부에 Finn chamber on Scanpor 테이프를 사용하여 24시간 동안 밀폐 첩포 한 후 피부의 반응을 육안으로 확인하였으며, 판정기준은 국제 접촉피부염 연구회의 판정인 표 2을 기준으로 판정하였다.Skin safety test of patch test of the cosmetic composition containing natural extract composite whitening improvement is Waggoner etc. (Waggoner WC, etc. Clinical safety and efficacy testing of cosmetic. Cosmetic science and Technology series. New York , Marcel Dekker . 1990: 105), the cosmetic composition containing the natural complex extract for whitening improvement prepared in Example 2 was applied to the skin on the inside of the plate using a Finn chamber on a Scanpor tape for 24 hours, The results were compared with those of the control group.
성인 남녀 각 50명을 대상으로 실시하였으며, 첩포 시험 결과를 표 3에 나타내었는데, 성인 남녀 모두 음성으로 확인되어 피부에 대한 안정성을 확인할 수 있었다.
The results of the patch test are shown in Table 3, and the adult male and female were confirmed to be negative and the skin stability was confirmed.
5050
50
따라서, 본 발명에 따른 피부 미백 복합추출 화장료 조성물은 항산화, 항염증이 우수하고, 세포독성이 없으며, 미백효과가 우수하여 피부를 밝고 건강하게 만들 수 있는 획기적인 조성물이다.
Accordingly, the skin whitening complex extract cosmetic composition according to the present invention is an epoch-making composition which is excellent in antioxidant and anti-inflammation, has no cytotoxicity, and has excellent whitening effect, thereby making the skin bright and healthy.
Claims (6)
상기 추출물은 지유 10~30중량%, 병풀 10~30중량%, 블루베리 10~20중량%, 가시오가피 10~20중량%, 상황버섯 5~10중량%, 차가버섯 5~10중량%를 혼합한 혼합물의 추출물인 것을 특징으로 하는 천연 미백복합 조성물.The method according to claim 1,
The extract was prepared by mixing 10 to 30% by weight of a fat base oil, 10 to 30% by weight of a herbage spoon, 10 to 20% by weight of a blueberry, 10 to 20% by weight of a sea bass, 5 to 10% by weight of a mushroom, and 5 to 10% ≪ / RTI > wherein the composition is an extract of the mixture.
상기 혼합물을 물 또는 에탄올 수용액으로 추출하여 추출물을 만드는 단계(단계 2); 및
상기 추출물을 여과 및 농축하여 피부 미백용 화장료 조성물을 제조하는 단계(단계 3);
를 포함하는 것을 특징으로 하는 천연 미백복합 조성물의 제조방법.10 to 30% by weight of ground oil, 10 to 30% by weight of blueberry, 10 to 20% by weight of blueberry, 10 to 20% by weight of gooseberry, 5 to 10% by weight of mushroom and 5 to 10% Step (step 1);
Extracting the mixture with water or an aqueous ethanol solution to prepare an extract (step 2); And
Filtering and concentrating the extract to prepare a cosmetic composition for skin whitening (step 3);
≪ / RTI > or a pharmaceutically acceptable salt thereof.
상기 혼합물에 8~10배 부피의 물을 넣고 80~85에서 2~4시간 동안 열수 추출하거나, 상기 혼합물에 8~10배 부피의 에탄올 수용액을 넣고 20~25에서 20~24시간 동안 용매 추출하되,
상기 에탄올 수용액은 에탄올과 물이 7:3의 부피비인 것을 특징으로 하는 천연 미백복합 조성물의 제조방법.4. The method of claim 3, wherein in step 2,
8 to 10 times volume of water is added to the mixture, followed by hot extraction at 80 to 85 ° C for 2 to 4 hours, or 8 to 10 times volume of an aqueous ethanol solution is added to the mixture, followed by solvent extraction at 20 to 25 for 20 to 24 hours ,
Wherein the ethanol aqueous solution has a volume ratio of ethanol to water of 7: 3.
상기 피부 미백용 화장료 조성물의 제조방법은 스킨, 로션, 에센스, 세럼, 크림, 아이크림, 마스크팩, 폼클렌저, 메이크업, 투웨이케익, 비비크림, 선크림, 바디케어제품, 헤어케어제품등으로 구성된 군으로부터 선택된 어느 하나의 제형인 것을 특징으로 하는 미백용 화장료 조성물.6. The method of claim 5,
The method for producing a cosmetic composition for skin whitening includes a skin, a lotion, an essence, a serum, a cream, an eye cream, a mask pack, a foam cleanser, a makeup, a two-way cake, a bib cream, a sunscreen, a body care product, Wherein the cosmetic composition is a cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140037547A KR20150113513A (en) | 2014-03-31 | 2014-03-31 | Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140037547A KR20150113513A (en) | 2014-03-31 | 2014-03-31 | Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150113513A true KR20150113513A (en) | 2015-10-08 |
Family
ID=54346430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140037547A KR20150113513A (en) | 2014-03-31 | 2014-03-31 | Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150113513A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919875A (en) * | 2016-06-12 | 2016-09-07 | 马殿伟 | Traditional Chinese medicine composition containing myrica rubra and applied to whitening cosmetics |
KR20190050388A (en) * | 2017-11-03 | 2019-05-13 | 한명애 | Natural shampoo using bamboo salt and manufacturing method thereof |
US11213477B2 (en) | 2016-12-21 | 2022-01-04 | Aqua Bio Technology Asa | Cosmetic composition comprising a Chaga extract and use thereof |
-
2014
- 2014-03-31 KR KR1020140037547A patent/KR20150113513A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105919875A (en) * | 2016-06-12 | 2016-09-07 | 马殿伟 | Traditional Chinese medicine composition containing myrica rubra and applied to whitening cosmetics |
US11213477B2 (en) | 2016-12-21 | 2022-01-04 | Aqua Bio Technology Asa | Cosmetic composition comprising a Chaga extract and use thereof |
KR20190050388A (en) * | 2017-11-03 | 2019-05-13 | 한명애 | Natural shampoo using bamboo salt and manufacturing method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101266180B1 (en) | Vegetable antibacterial composition and cosmetic composition for improving skin using the same | |
KR101824770B1 (en) | Anti-wrinkle cosmetic composition comprising essentially Polygonum multiflorum adventitious extract | |
KR20160021676A (en) | Cosmetic Compositions with Whitening and Anti-oxidative Effect Comprising of Phragmitis Rhizoma, Salicomia herbacea L. and Prunus mume | |
KR20190028996A (en) | Cosmetic composition for protecting skin from UV which comprises extract of bitter ground, persimmon leaf and ceramium kondoi | |
KR20150113513A (en) | Composition for whitening cosmetics comprising natural complex extracts with the effect of whitening | |
KR102063686B1 (en) | Skin external composition containing extract of soybean root | |
KR20150136887A (en) | Cosmetic composition comprising extract of Brassica Rapa, Brassica Rapa radish leaves or Brassica Rapa callus with anti-oxidant, astringent activity and skin wrinkle improvement effect and the manufacturing method thereof | |
KR20110138984A (en) | Cosmetic composition for improving skin using gombo-baechu and manufacturing method thereof | |
KR20100121352A (en) | A composition comprising complex crude drug extract for anti-aging and improvement of skin | |
KR101837020B1 (en) | Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same | |
KR101700105B1 (en) | A composition for antioxidating, whitening and improving wrinkle comprising extracts of false indigo | |
KR20180043567A (en) | Functional cosmetic composition with nipa fruticans wurmb | |
KR20120051216A (en) | Manufacturing process and natural preservative of cosmetic | |
KR20150081051A (en) | Cosmetic Compositon for Whitening Comprising Natural Complex Extract As Active Ingredient | |
KR101214347B1 (en) | Method for Extracting Herbal Ingredient | |
KR20090002369A (en) | Cosmetic composition with the antioxidant effect protecting skins aging | |
KR102471009B1 (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR101093901B1 (en) | A cosmetic composition comprising an extract of tissue cultured anoectochilus formosanus and a preparation method of the extract of tissue cultured anoectochilus formosanus | |
KR100466379B1 (en) | Composition for skin whitening | |
JP2003089630A (en) | Bleaching agent | |
KR20130001027A (en) | Skin whitening cosmetic composition having zanthoxylum schinitolium extract and preparation method thereof | |
KR101317433B1 (en) | The cosmetic composition for skin whitening comprising the mixture of extract of Hovenia dulcia, Platycodon grandiflorum, wheat bud and sage | |
KR20040023446A (en) | The ethanol extract from Ephedra sinica Stapf which have ability of whitening, anti-wrinkle and anti-aging effect in the cosmetic | |
KR100190989B1 (en) | Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof | |
KR20060133608A (en) | The herbal composition having the skin antiaging and antiwrinkling function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |